Rosopatamab
Product Specifications
CAS Number
2260767-49-3
Target
PSMA
Related Pathways
Immunology/Inflammation
Purity
0.951
Bioactivity
Rosopatamab is a humanized monoclonal antibody targeting prostate-specific membrane antigen (PSMA) for the treatment of prostate cancer. It can be conjugated with radiolabeled isotopes (e.g., 177Lu) via DOTA-NHS ester to form radiopharmaceuticals for targeted therapy. In preclinical studies, 177Lu-DOTA-Rosopatamab combined with the DNA-PK inhibitor Peposertib achieved a 75% complete response rate in prostate cancer mouse models.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C5062-69A-PE 200 µL
CHK, CT (Choline Kinase alpha, CK, CHETK-alpha, Ethanolamine Kinase, EK, CHKA, CKI) (PE) discontinued
Sign In for Pricing
View Details 
A133134 100 µL
Anti-IL23R Nanobody (SAA2269) (Alpaca, Monoclonal, VHH-Fc)
Sign In for Pricing
View Details GTR15182163 1 Vial
Lentiviral mouse Clpb shRNA (UAS) - Lentiviral mouse Clpb shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details